| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $252.7M | +66.0% |
| Cost of Revenue | $30.0M | +62.4% |
| Gross Profit | $222.7M | +66.5% |
| R&D Expense | $97.2M | -8.8% |
| SG&A Expense | $63.7M | -26.7% |
| Operating Income | -$129.0M | +39.7% |
| Pre-tax Income | -$159.1M | +16.0% |
| Income Tax | -$1.5M | -153.4% |
| Net Income | -$155.1M |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $884.7M | +212.8% |
| Short-term Investments | $50.0M | — |
| Accounts Receivable | $77.2M | +94.8% |
| Current Assets | $1.05B | +201.8% |
| Total Assets | $1.09B | +201.0% |
| Current Liabilities | $241.6M | +90.0% |
| Total Liabilities | $292.2M | +73.0% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.8M | +32.3% |
| Capital Expenditures | $3.5M | — |
| Investing Cash Flow | -$53.9M | -6300.8% |
| Financing Cash Flow | $701.2M | +5316.6% |
| Free Cash Flow | -$53.4M | +27.5% |
| +19.3% |
| EPS (Basic) | -$1.95 | +49.0% |
| EPS (Diluted) | -$1.95 | +49.0% |
| Stockholders' Equity |
| $774.9M |
| +435.1% |